Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Ingrid Binswanger to Analgesics, Opioid

This is a "connection" page, showing publications Ingrid Binswanger has written about Analgesics, Opioid.

 
Connection Strength
  
 
 
7.428
  
  1. Pytell JD, Narwaney KJ, Nguyen AP, Glanz JM, Binswanger IA. New Alcohol-related Condition Diagnoses Are Associated With Opioid Tapers Among Patients Receiving Long-term Opioid Therapy. J Addict Med. 2025 May-Jun 01; 19(3):290-297.
    View in: PubMed
    Score: 0.467
  2. Binswanger IA, Shetterly SM, Xu S, Narwaney KJ, McClure DL, Rinehart DJ, Nguyen AP, Glanz JM. Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment. JAMA Netw Open. 2022 10 03; 5(10):e2234671.
    View in: PubMed
    Score: 0.402
  3. Binswanger IA, Glanz JM, Faul M, Shoup JA, Quintana LM, Lyden J, Xu S, Narwaney KJ. The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study. Drug Alcohol Depend. 2020 12 01; 217:108248.
    View in: PubMed
    Score: 0.348
  4. Nguyen AP, Glanz JM, Narwaney KJ, Binswanger IA. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults. JAMA Netw Open. 2020 03 02; 3(3):e201018.
    View in: PubMed
    Score: 0.336
  5. Lyden J, Binswanger IA. The United States opioid epidemic. Semin Perinatol. 2019 04; 43(3):123-131.
    View in: PubMed
    Score: 0.311
  6. Peglow SL, Binswanger IA. Preventing Opioid Overdose in the Clinic and Hospital: Analgesia and Opioid Antagonists. Med Clin North Am. 2018 Jul; 102(4):621-634.
    View in: PubMed
    Score: 0.299
  7. Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA. Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy. J Gen Intern Med. 2018 10; 33(10):1646-1653.
    View in: PubMed
    Score: 0.291
  8. Mueller SR, Koester S, Glanz JM, Gardner EM, Binswanger IA. Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain. J Gen Intern Med. 2017 Mar; 32(3):277-283.
    View in: PubMed
    Score: 0.267
  9. Frank JW, Levy C, Matlock DD, Calcaterra SL, Mueller SR, Koester S, Binswanger IA. Patients' Perspectives on Tapering of Chronic Opioid Therapy: A Qualitative Study. Pain Med. 2016 10; 17(10):1838-1847.
    View in: PubMed
    Score: 0.259
  10. Calcaterra SL, Drabkin AD, Leslie SE, Doyle R, Koester S, Frank JW, Reich JA, Binswanger IA. The hospitalist perspective on opioid prescribing: A qualitative analysis. J Hosp Med. 2016 08; 11(8):536-42.
    View in: PubMed
    Score: 0.258
  11. Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use. J Gen Intern Med. 2016 May; 31(5):478-85.
    View in: PubMed
    Score: 0.258
  12. Bartels K, Mayes LM, Dingmann C, Bullard KJ, Hopfer CJ, Binswanger IA. Opioid Use and Storage Patterns by Patients after Hospital Discharge following Surgery. PLoS One. 2016; 11(1):e0147972.
    View in: PubMed
    Score: 0.253
  13. Binswanger IA, Gordon AJ. From risk reduction to implementation: Addressing the opioid epidemic and continued challenges to our field. Subst Abus. 2016; 37(1):1-3.
    View in: PubMed
    Score: 0.252
  14. Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff. J Gen Intern Med. 2015 Dec; 30(12):1837-44.
    View in: PubMed
    Score: 0.250
  15. Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice. Subst Abus. 2015; 36(2):240-53.
    View in: PubMed
    Score: 0.238
  16. Calcaterra SL, Keniston A, Blum J, Crume T, Binswanger IA. The Association Between Stimulant, Opioid, and Multiple Drug Use on Behavioral Health Care Utilization in a Safety-Net Health System. Subst Abus. 2015; 36(4):407-12.
    View in: PubMed
    Score: 0.238
  17. Binswanger IA, Glanz JM. Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice. Subst Abus. 2015; 36(2):141-3.
    View in: PubMed
    Score: 0.237
  18. Guan X, Jurecka C, Padmanabhan P, Yamkovoy K, Christine PJ, Binswanger IA, Glanz JM, Kline DM, Barocas JA. Impact of increased criminal penalties for fentanyl possession on initiation and retention on medications for opioid use disorder in Colorado. Int J Drug Policy. 2025 12; 146:105037.
    View in: PubMed
    Score: 0.124
  19. Metz VE, Palzes VA, Binswanger IA, Altschuler A, Poulsen MN, Ahmedani BK, Andrade SE, Clark RE, Hechter RC, Horberg MA, Sanchez K, Bailey SR, Stephens KA, Rubinstein AL, Campbell CI. Risks for Adverse Events by Sex and Age After Prescription Opioid Dose Reduction: A Secondary Analysis Across 8 U.S. Health Systems. Am J Prev Med. 2025 Dec; 69(6):108085.
    View in: PubMed
    Score: 0.123
  20. McClure DL, Binswanger IA, Narwaney KJ, Ford MA, Nguyen AP, Rinehart DJ, Glanz JM. Patterns of long-term opioid therapy with prior nonpharmacologic pain management utilization. Sci Rep. 2025 Aug 29; 15(1):31924.
    View in: PubMed
    Score: 0.123
  21. Jurecka C, Adams J, Padmanabhan P, Glanz J, Christine P, Guan X, Kline D, Binswanger I, Barocas J. Implementation of a Statewide Fentanyl Possession Law and Opioid-Related Overdose Deaths. JAMA Health Forum. 2025 Aug 01; 6(8):e252654.
    View in: PubMed
    Score: 0.122
  22. Pytell JD, Christine PJ, LeMasters K, Rockhill KM, Black JC, Dart RC, Binswanger IA. Comparison of heroin and fentanyl use in US nationally representative surveys. Addict Sci Clin Pract. 2025 02 11; 20(1):13.
    View in: PubMed
    Score: 0.118
  23. Pytell JD, Binswanger IA. Addressing Opioid Use Disorder in Primary Care: Revisiting Core Primary Care Principles to Confidently Initiate Treatment. J Gen Intern Med. 2024 07; 39(9):1749-1750.
    View in: PubMed
    Score: 0.111
  24. Glanz JM, Xu S, Narwaney KJ, McClure DL, Rinehart DJ, Ford MA, Nguyen AP, Binswanger IA. Association Between Opioid Dose Reduction Rates and Overdose Among Patients Prescribed Long-Term Opioid Therapy. Subst Abus. 2023 07; 44(3):209-219.
    View in: PubMed
    Score: 0.107
  25. Nguyen AP, Glanz JM, Narwaney KJ, Zeng C, Wright L, Fairbairn LM, Binswanger IA. Update of a Multivariable Opioid Overdose Risk Prediction Model to Enhance Clinical Care for Long-term Opioid Therapy Patients. J Gen Intern Med. 2023 09; 38(12):2678-2685.
    View in: PubMed
    Score: 0.104
  26. Lyden JR, Xu S, Narwaney KJ, Glanz JM, Binswanger IA. Opioid Overdose Risk Following Hospital Discharge Among Individuals Prescribed Long-Term Opioid Therapy: a Risk Interval Analysis. J Gen Intern Med. 2023 08; 38(11):2560-2567.
    View in: PubMed
    Score: 0.103
  27. Binswanger IA, Rinehart D, Mueller SR, Narwaney KJ, Stowell M, Wagner N, Xu S, Hanratty R, Blum J, McVaney K, Glanz JM. Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic Trial. J Gen Intern Med. 2022 08; 37(11):2624-2633.
    View in: PubMed
    Score: 0.096
  28. Nguyen AP, Glanz JM, Shoup JA, Campbell CI, Clarke CL, Ford MA, Binswanger IA. Mortality Among Patients Prescribed Buprenorphine for Opioid Use Disorder After Disenrollment from an Insurance Plan and Healthcare System. J Gen Intern Med. 2022 08; 37(11):2882-2884.
    View in: PubMed
    Score: 0.096
  29. Calcaterra SL, Lockhart S, Callister C, Hoover K, Binswanger IA. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers. J Gen Intern Med. 2022 08; 37(11):2786-2794.
    View in: PubMed
    Score: 0.095
  30. Mueller SR, Glanz JM, Nguyen AP, Stowell M, Koester S, Rinehart DJ, Binswanger IA. Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose. Int J Drug Policy. 2021 06; 92:103077.
    View in: PubMed
    Score: 0.089
  31. Krsak M, Montague BT, Trowbridge P, Johnson SC, Binswanger IA. Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications. J Infect Dis. 2020 09 02; 222(Suppl 5):S486-S493.
    View in: PubMed
    Score: 0.087
  32. Frank JW, Binswanger IA. Commentary on Rhee & Rosenheck (2019): Buprenorphine prescribing for opioid use disorder in medical practice - can office-based out-patient care address the opiate crisis in the United States? Addiction. 2020 04; 115(4):786-787.
    View in: PubMed
    Score: 0.083
  33. Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020 02 01; 207:107732.
    View in: PubMed
    Score: 0.082
  34. Glanz JM, Binswanger IA, Shetterly SM, Narwaney KJ, Xu S. Association Between Opioid Dose Variability and Opioid Overdose Among Adults Prescribed Long-term Opioid Therapy. JAMA Netw Open. 2019 04 05; 2(4):e192613.
    View in: PubMed
    Score: 0.079
  35. Binswanger IA, Narwaney KJ, Gardner EM, Gabella BA, Calcaterra SL, Glanz JM. Development and evaluation of a standardized research definition for opioid overdose outcomes. Subst Abus. 2019; 40(1):71-79.
    View in: PubMed
    Score: 0.079
  36. Kennedy LC, Binswanger IA, Mueller SR, Levy C, Matlock DD, Calcaterra SL, Koester S, Frank JW. "Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications. Pain Med. 2018 11 01; 19(11):2201-2211.
    View in: PubMed
    Score: 0.077
  37. Binswanger IA, Glanz JM. Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone. Drug Saf. 2018 10; 41(10):979-980.
    View in: PubMed
    Score: 0.076
  38. Binswanger IA. Commentary on Hsu et al. (2017): A systems approach to improving health services for overdose in the hospital and across the continuum of care-an unmet need. Addiction. 2017 09; 112(9):1565-1566.
    View in: PubMed
    Score: 0.071
  39. Metz TD, Rovner P, Hoffman MC, Allshouse AA, Beckwith KM, Binswanger IA. Maternal Deaths From Suicide and Overdose in Colorado, 2004-2012. Obstet Gynecol. 2016 12; 128(6):1233-1240.
    View in: PubMed
    Score: 0.067
  40. Davis CS, Burris S, Beletsky L, Binswanger I. Co-prescribing naloxone does not increase liability risk. Subst Abus. 2016 Oct-Dec; 37(4):498-500.
    View in: PubMed
    Score: 0.066
  41. Bartels K, Binswanger IA, Hopfer CJ. Sources of Prescription Opioids for Nonmedical Use. J Addict Med. 2016 Mar-Apr; 10(2):134.
    View in: PubMed
    Score: 0.064
  42. Nguyen AP, Palzes VA, Binswanger IA, Ahmedani BK, Altschuler A, Andrade SE, Bailey SR, Clark RE, Haller IV, Hechter RC, Karmali R, Metz VE, Poulsen MN, Roblin DW, Rosa CL, Rubinstein AL, Sanchez K, Stephens KA, Yarborough BJH, Campbell CI. Association of initial opioid prescription duration and an opioid refill by pain diagnosis: Evidence from outpatient settings in ten US health systems. Prev Med. 2024 02; 179:107828.
    View in: PubMed
    Score: 0.027
  43. Xu S, Narwaney KJ, Nguyen AP, Binswanger IA, McClure DL, Glanz JM. An individual segmented trajectory approach for identifying opioid use patterns using longitudinal dispensing data. Pharmacoepidemiol Drug Saf. 2024 01; 33(1):e5708.
    View in: PubMed
    Score: 0.027
  44. Shoup JA, Welter J, Binswanger IA, Hess F, Dullenkopf A, Coker J, Berliner J. Spinal cord injury and prescribed opioids for pain: a scoping review. Pain Med. 2023 10 03; 24(10):1138-1152.
    View in: PubMed
    Score: 0.027
  45. Glanz JM, Binswanger IA, Clarke CL, Nguyen AP, Ford MA, Ray GT, Xu S, Hechter RC, Yarborough BJH, Roblin DW, Ahmedani B, Boscarino JA, Andrade SE, Rosa CL, Campbell CI. The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment. Addiction. 2023 01; 118(1):97-107.
    View in: PubMed
    Score: 0.025
  46. Braciszewski JM, Idu AE, Yarborough BJH, Stumbo SP, Bobb JF, Bradley KA, Rossom RC, Murphy MT, Binswanger IA, Campbell CI, Glass JE, Matson TE, Lapham GT, Loree AM, Barbosa-Leiker C, Hatch MA, Tsui JI, Arnsten JH, Stotts A, Horigian V, Hutcheson R, Bart G, Saxon AJ, Thakral M, Ling Grant D, Pflugeisen CM, Usaga I, Madziwa LT, Silva A, Boudreau DM. Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder. Psychiatr Serv. 2022 12 01; 73(12):1330-1337.
    View in: PubMed
    Score: 0.025
  47. Bagley SM, Chavez L, Braciszewski JM, Akolsile M, Boudreau DM, Lapham G, Campbell CI, Bart G, Yarborough BJH, Samet JH, Saxon AJ, Rossom RC, Binswanger IA, Murphy MT, Glass JE, Bradley KA. Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems. Addict Sci Clin Pract. 2021 07 07; 16(1):46.
    View in: PubMed
    Score: 0.023
  48. Shoup JA, Mueller SR, Binswanger IA, Williams AV, Strang J, Glanz JM. Modifying and Evaluating the Opioid Overdose Knowledge Scale for Prescription Opioids: A Pilot Study of the Rx-OOKS. Pain Med. 2020 10 01; 21(10):2244-2252.
    View in: PubMed
    Score: 0.022
  49. Calcaterra SL, Scarbro S, Hull ML, Forber AD, Binswanger IA, Colborn KL. Prediction of Future Chronic Opioid Use Among Hospitalized Patients. J Gen Intern Med. 2018 06; 33(6):898-905.
    View in: PubMed
    Score: 0.018
  50. Calcaterra SL, Drabkin AD, Doyle R, Leslie SE, Binswanger IA, Frank JW, Reich JA, Koester S. A Qualitative Study of Hospitalists' Perceptions of Patient Satisfaction Metrics on Pain Management. Hosp Top. 2017 Jan-Mar; 95(1):18-26.
    View in: PubMed
    Score: 0.017
  51. Merrall EL, Kariminia A, Binswanger IA, Hobbs MS, Farrell M, Marsden J, Hutchinson SJ, Bird SM. Meta-analysis of drug-related deaths soon after release from prison. Addiction. 2010 Sep; 105(9):1545-54.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)